Biomarin Pharmaceutical Inc (BMRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Biomarin Pharmaceutical Inc-Aktie (BMRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.77% 825.41	745.14	747.31	745.74	712.03
Cost Of Revenue	0.97% 150.09	151.56	136.14	188.46	130.46
Gross Profit	13.77% 675.32	593.59	611.17	557.28	581.57
Operating Expenses	7.77% 398.43	369.69	449.77	443.39	461.12
Benefits Costs and Expenses	4.04% 527.54	507.06	577.67	611.30	579.89
Costs And Expenses	5.23% 548.52	521.25	585.91	631.85	591.58
Operating Income/Loss	23.67% 276.89	223.89	161.41	113.89	120.45
Income/Loss From Continuing Operations Before Tax	25.11% 297.87	238.09	169.64	134.44	132.14
Income Tax Expense/Benefit, Deferred	17.28% 33.34	28.43	42.39	12.17	1.252
Income Tax Expense/Benefit	9.41% 57.34	52.40	44.70	28.36	24.96
Income/Loss From Continuing Operations After Tax	29.54% 240.53	185.69	124.94	106.08	107.17
Net Income/Loss	29.54% 240.53	185.69	124.94	106.08	107.17
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.49% 191.91	190.97	0.221	190.43	190.11
Diluted Average Shares	0.31% 197.09	196.47	0.025	197.15	200.50
Basic Earnings Per Share	28.87% 1.25	0.97	0.66	0.56	0.56
Diluted Earnings Per Share	29.47% 1.23	0.95	0.65	0.55	0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$85.44

1.75%

GMAB

$27.38

1.11%

SMMT

$23.80

1.19%

BNTX

$103.50

3.07%

INSM

$142.53

0.68%

ONC

$318.73

5.21%